{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:58:59Z","timestamp":1781845139112,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Many of the anaesthetic drugs used for electroconvulsive therapy have anticonvulsant properties and may influence efficacy of electroconvulsive therapy. With this study we aim to provide more information on the effect of etomidate and methohexital on seizure duration. We explore the relationship between induction drug, motor and electroencephalography seizure duration. Moreover, we study the relationship of seizure duration and number of therapies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this retrospective study we collected data from patient records from 2005 until 2016. Inclusion criteria were the use of etomidate and\/or methohexital and documentation of dosage, electroconvulsive therapy dosage and seizure duration. Exclusion criteria were missing data on either induction drug, dosage or seizure duration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty seven patients were analysed. The mean age was 52\u00a0years and seventy six percent were female. Most patients were suffering from affective disorders (81%). Motor and electroencephalography seizure duration were analysed in 679 and 551 electroconvulsive therapies, respectively. Compared to methohexital, motor and electroencephalography seizures under etomidate were 7 and 13\u00a0s longer, respectively. Furthermore, there was a negative association between seizure duration and number of treatment and a negative association between seizure duration and electroconvulsive therapy dosage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study demonstrates significant longer motor and electroencephalography seizure duration using etomidate compared to methohexital. Etomidate might therefore increase the effectiveness of electroconvulsive therapy. Moreover, we observed a negative association between seizure duration, number of treatment and electroconvulsive therapy dosage. With this study we contribute to the available literature comparing methohexital and etomidate as induction agents for electroconvulsive therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12871-022-01745-y","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T07:02:54Z","timestamp":1657004574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The influence of anaesthetic choice on seizure duration of electroconvulsive therapy; etomidate versus methohexital"],"prefix":"10.1186","volume":"22","author":[{"given":"Laila","family":"Chomrikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Martijn","family":"Kuijper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris J. B.","family":"van der Vlugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppe J. H. A.","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"issue":"9360","key":"1745_CR1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","volume":"361","author":"Group UER","year":"2003","unstructured":"Group UER. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361(9360):799\u2013808.","journal-title":"Lancet"},{"issue":"5","key":"1745_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1600-0447.1991.tb03172.x","volume":"84","author":"M Fink","year":"1991","unstructured":"Fink M. What is an adequate treatment in convulsive therapy? Acta Psychiatr Scand. 1991;84(5):424\u20137.","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"1745_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/070674379604100507","volume":"41","author":"FR Lalla","year":"1996","unstructured":"Lalla FR, Milroy T. The current status of seizure duration in the practice of electroconvulsive therapy. Can J Psychiatry. 1996;41(5):299\u2013304.","journal-title":"Can J Psychiatry"},{"issue":"1","key":"1745_CR4","first-page":"32","volume":"57","author":"B Shapira","year":"1996","unstructured":"Shapira B, Lidsky D, Gorfine M, Lerer B. Electroconvulsive therapy and resistant depression: clinical implications of seizure threshold. J Clin Psychiatry. 1996;57(1):32\u20138.","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"1745_CR5","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/gps.700","volume":"17","author":"SM Benbow","year":"2002","unstructured":"Benbow SM. The practice of electroconvulsive therapy recommendations for treatment, training and privileging. A task force report of the american psychiatric association, 2nd edition. American psychiatric association, Washington, DC, 2001. Pages: 355. Int J Geriatr Psychiatry. 2002;17(11):1081\u20131081.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"1745_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/YCT.0b013e31815bfe2a","volume":"24","author":"WM Hooten","year":"2008","unstructured":"Hooten WM, Rasmussen KG Jr. Effects of general anesthetic agents in adults receiving electroconvulsive therapy: a systematic review. J ECT. 2008;24(3):208\u201323.","journal-title":"J ECT"},{"issue":"5","key":"1745_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4103\/ija.IJA_132_17","volume":"61","author":"PK Kadiyala","year":"2017","unstructured":"Kadiyala PK, Kadiyala LD. Anaesthesia for electroconvulsive therapy: an overview with an update on its role in potentiating electroconvulsive therapy. Indian J Anaesth. 2017;61(5):373\u201380.","journal-title":"Indian J Anaesth"},{"issue":"4","key":"1745_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/YCT.0000000000000212","volume":"31","author":"PM Singh","year":"2015","unstructured":"Singh PM, Arora S, Borle A, Varma P, Trikha A, Goudra BG. Evaluation of etomidate for seizure duration in electroconvulsive therapy: a systematic review and meta-analysis. J ECT. 2015;31(4):213\u201325.","journal-title":"J ECT"},{"issue":"4","key":"1745_CR9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/aas.12289","volume":"58","author":"G Erdoes","year":"2014","unstructured":"Erdoes G, Basciani RM, Eberle B. Etomidate\u2013a review of robust evidence for its use in various clinical scenarios. Acta Anaesthesiol Scand. 2014;58(4):380\u20139.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"3","key":"1745_CR10","first-page":"596","volume":"81","author":"MN Avramov","year":"1995","unstructured":"Avramov MN, Husain MM, White PF. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg. 1995;81(3):596\u2013602.","journal-title":"Anesth Analg"},{"key":"1745_CR11","unstructured":"Van den Broek WW, Birkenhager, T.K., de Boer, D., Burggraaf, J.P., van Gemert, B., Groenland, T.H.N., Kho, K.H., Stek, M.L., Verwey, B., van Vliet, I.M., van waarde, J.A., Wijkstra, J.: Richtlijn Elektroconvulsietherapie. Nederlandse Vereniging voor Psychiatrie 2010."},{"issue":"2 Pt 2","key":"1745_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3109\/15622970902960897","volume":"11","author":"D Eser","year":"2010","unstructured":"Eser D, Nothdurfter C, Schule C, Damm J, Steng Y, Moller HJ, Rupprecht R, Baghai T. The influence of anaesthetic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry. 2010;11(2 Pt 2):447\u201356.","journal-title":"World J Biol Psychiatry"},{"issue":"2","key":"1745_CR13","first-page":"118","volume":"8","author":"AL Kovac","year":"1992","unstructured":"Kovac AL, Pardo M. A comparison between etomidate and methohexital for anesthesia in ECT. Convuls Ther. 1992;8(2):118\u201325.","journal-title":"Convuls Ther"},{"issue":"5","key":"1745_CR14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jpsychires.2012.12.019","volume":"47","author":"H Janouschek","year":"2013","unstructured":"Janouschek H, Nickl-Jockschat T, Haeck M, Gillmann B, Grozinger M. Comparison of methohexital and etomidate as anesthetic agents for electroconvulsive therapy in affective and psychotic disorders. J Psychiatr Res. 2013;47(5):686\u201393.","journal-title":"J Psychiatr Res"},{"issue":"1\u20132","key":"1745_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jad.2008.03.004","volume":"113","author":"SV Eranti","year":"2009","unstructured":"Eranti SV, Mogg AJ, Pluck GC, Landau S, McLoughlin DM. Methohexitone, propofol and etomidate in electroconvulsive therapy for depression: a naturalistic comparison study. J Affect Disord. 2009;113(1\u20132):165\u201371.","journal-title":"J Affect Disord"},{"issue":"2","key":"1745_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/15622970500213871","volume":"7","author":"TC Baghai","year":"2006","unstructured":"Baghai TC, Marcuse A, Brosch M, Sch\u00fcle C, Eser D, Nothdurfter C, Steng Y, Noack I, Pietschmann K, M\u00f6ller HJ, et al. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry. 2006;7(2):82\u201390.","journal-title":"World J Biol Psychiatry"},{"issue":"1","key":"1745_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/10401238909149862","volume":"1","author":"R Boccio","year":"1989","unstructured":"Boccio R, Fink M. A comparison of etomidate and methohexital anesthesia for electroconvulsive therapy. Ann Clin Psychiatry. 1989;1(1):39\u201342.","journal-title":"Ann Clin Psychiatry"},{"issue":"4","key":"1745_CR18","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.brs.2021.05.016","volume":"14","author":"J Luccarelli","year":"2021","unstructured":"Luccarelli J, McCoy TH Jr, Seiner SJ, Henry ME. Changes in seizure duration during acute course electroconvulsive therapy. Brain Stimul. 2021;14(4):941\u20136.","journal-title":"Brain Stimul"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01745-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-022-01745-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01745-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T07:04:56Z","timestamp":1657004696000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-022-01745-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1745"],"URL":"https:\/\/doi.org\/10.1186\/s12871-022-01745-y","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,5]]},"assertion":[{"value":"21 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the medical ethical committee (Toetsingscommissie Wetenschappelijk Onderzoek Rotterdam en omstreken; TWOR, 2016\u201361) and the need for written informed consent was waived. This study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}